Norleual (TFA)
Norleual TFA, an angiotensin (Ang) IV analog, is a hepatocyte growth factor (HGF) /c-Met inhibitor with an IC50 of 3 pM. Norleual TFA is an AT4 receptor antagonist and exhibits potent antiangiogenic activities[1].
Product Specifications
UNSPSC
12352209
Target
Angiotensin Receptor; c-Met/HGFR
Type
Peptides
Related Pathways
GPCR/G Protein; Protein Tyrosine Kinase/RTK
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease; Neurological Disease; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/norleual-tfa.html
Purity
99.93
Solubility
H2O : ≥ 50 mg/mL
Smiles
O=C(N(CCC1)[C@@H]1C(N[C@H](C(O)=O)CC2=CC=CC=C2)=O)[C@@H](NC[C@H](CC(C)C)NC([C@@H](NC([C@@H](N)CCCC)=O)CC(C=C3)=CC=C3O)=O)CC4=CN=CN4.O=C(O)C(F)(F)F
Molecular Formula
C43H59F3N8O9
Molecular Weight
888.97
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light, under nitrogen)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
